Comparison of the Effects of Robotic Rehabilitation, Functional Electrical Stimulation and Occupational Therapy on Upper Extremity and Hand Functions in Tetraplegic Patients With Spinal Cord Injury
Launched by ANKARA CITY HOSPITAL BILKENT · Mar 29, 2025
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how three different types of rehabilitation therapies—robotic rehabilitation, functional electrical stimulation (FES), and occupational therapy—help improve the use of arms and hands in patients with tetraplegia, which is a condition where individuals lose movement in all four limbs due to spinal cord injury. The goal is to discover which therapy works best for different groups of patients based on their individual needs and to help develop personalized rehabilitation strategies.
To participate in this trial, individuals must be at least 18 years old and have incomplete tetraplegia, meaning they have some movement or sensation in their arms or legs. They should also be able to sit up for at least 30 minutes and have no serious cognitive or visual impairments. Participants will undergo these therapies and be monitored for improvements in their upper body function. This study is important because it aims to provide clearer guidance on the best rehabilitation options for tetraplegic patients, ultimately helping them regain more independence in their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years
- • Incomplete tetraplegia
- • No cognitive impairment (Mini-Mental State Exam score ≥25)
- • No significant visual deficits
- • Ability to sit upright for at least 30 minutes
- • No prior exposure to these treatments in the last six months
- Exclusion Criteria:
- • Severe upper extremity spasticity (MAS score 3-4)
- • Severe shoulder pain or joint ROM restriction (\>50%)
- • Pre-existing neurological, rheumatological, or orthopedic conditions affecting upper extremity
- • Severe cardiovascular disease
- • Uncontrolled aggressive behavior
- • Open wounds or infections at application sites
- • Aphasia affecting comprehension
- • Active deep vein thrombosis or thrombophlebitis in the upper extremity
- • History of epilepsy or cyber disease
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported